Microenvironment targets in KRAS-mutated metastatic colorectal cancer

被引：0
|
作者：
Marchio, Serena [1 ]
Bartolini, Alice [1 ]
Cardaci, Sabrina [2 ]
Soster, Marco [2 ]
Corti, Giorgio [1 ]
Lamba, Simona [1 ]
Bussolino, Federico [2 ]
Cora', Davide [1 ]
Nicolantonio, Federica D. [2 ]
机构：
[1] Inst Canc Res & Treatment, Candiolo, Italy
[2] Univ Turin, Candiolo, Italy
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-1163
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1163
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Advanced therapies on BRAF-mutated and KRAS-mutated metastatic colorectal cancer
    LI Zi-nan
    YU Li-feng
    WANG Jia-qi
    NIU Yan-xin
    WANG Xin-yu
    ZHAO Lin
    中国药理学与毒理学杂志, 2019, (10) : 883 - 883
  • [2] Sotorasib in KRAS-Mutated Colorectal Cancer Reply
    Fakih, Marwan G.
    Chao, Joseph
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (02): : 187 - 187
  • [3] MicroRNA signature associated with KRAS-mutated colorectal cancer
    Andreoiu, O-M
    Dobre, M.
    Pirvu, I-R
    Vasilescu, F.
    Herlea, V.
    Becheanu, G.
    VIRCHOWS ARCHIV, 2017, 471 : S161 - S162
  • [4] Polo-like Kinase 1 Inhibition in KRAS-Mutated Metastatic Colorectal Cancer
    Stebbing, Justin
    Bullock, Andrea J.
    CLINICAL CANCER RESEARCH, 2024, 30 (10) : 2005 - 2007
  • [5] Novel modalities in the treatment of patients with KRAS-mutated colorectal cancer
    Dimou, Anastasios
    Syrigos, Konstantinos
    Saif, Muhammad Wasif
    ANTI-CANCER DRUGS, 2011, 22 (05) : 384 - 391
  • [6] KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer
    Spindler, K. G.
    Appelt, A. L.
    Pallisgaard, N.
    Andersen, R. F.
    Jakobsen, A.
    BRITISH JOURNAL OF CANCER, 2013, 109 (12) : 3067 - 3072
  • [7] KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer
    K G Spindler
    A L Appelt
    N Pallisgaard
    R F Andersen
    A Jakobsen
    British Journal of Cancer, 2013, 109 : 3067 - 3072
  • [8] The Therapeutic Landscape for KRAS-Mutated Colorectal Cancers
    Tria, Simon Manuel
    Burge, Matthew E.
    Whitehall, Vicki L. J.
    CANCERS, 2023, 15 (08)
  • [9] MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer
    Yamasaki, Juntaro
    Hirata, Yuki
    Otsuki, Yuji
    Suina, Kentaro
    Saito, Yoshiyuki
    Masuda, Kenta
    Okazaki, Shogo
    Ishimoto, Takatsugu
    Saya, Hideyuki
    Nagano, Osamu
    CANCER SCIENCE, 2022, 113 (03) : 916 - 925
  • [10] MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer
    Yamasaki, Juntaro
    Otsuki, Yuji
    Masuda, Kenta
    Saya, Hideyuki
    Nagano, Osamu
    CANCER SCIENCE, 2023, 114 : 296 - 296
12345